Valuation: Getinge AB

Market Cap 63.84B 6.59B 5.68B 5.38B 4.87B 9.14B 629B 9.19B 24.55B 320B 24.75B 24.2B 1,012B P/E 2026 *
20.2x
P/E 2027 * 18.1x
Enterprise Value 72.04B 7.44B 6.41B 6.07B 5.5B 10.31B 710B 10.37B 27.7B 361B 27.92B 27.31B 1,142B EV / Sales 2026 *
2.04x
EV / Sales 2027 * 1.87x
Free-Float
79.13%
Yield 2026 *
2.21%
Yield 2027 * 2.39%
1 day-0.88%
1 week-4.42%
Current month-6.08%
1 month-3.56%
3 months+15.37%
6 months+21.73%
Current year+1.86%
1 week 24.09
Extreme 24.09
24.92
1 month 24.09
Extreme 24.09
25.98
Current year 18.99
Extreme 18.99
25.98
1 year 18.99
Extreme 18.99
25.98
3 years 14.84
Extreme 14.84
25.98
5 years 14.84
Extreme 14.84
48.89
10 years 8.31
Extreme 8.31
48.89
Manager TitleAgeSince
Chief Executive Officer 54 30/04/2017
Director of Finance/CFO 48 30/03/2024
Compliance Officer 47 30/09/2020
Director TitleAgeSince
Chairman 65 22/04/2019
Chairman 75 -
Director/Board Member 70 31/12/2006
Change 5-day change 1-year change 3-year change Capi.($)
-0.88%-4.42% - - 6.59B
-0.02%-1.38%+16.50%+13.78% 12.52B
+1.54%-2.30%+12.32%+16.84% 6.59B
+0.27%-3.37% - - 6.33B
+1.91%-5.00%+22.56%+8.93% 5.51B
+1.23%-3.40%-19.07%+38.52% 5.04B
-0.24%-1.71%-35.10%-24.58% 3.76B
+1.04%-13.55%+27.65%-22.22% 1.81B
+0.16%+7.01%-1.13%+165.08% 1.78B
+1.46%-3.79%+44.50%-18.11% 1.57B
Average +0.65%-3.58%+8.53%+22.28% 4.99B
Weighted average by Cap. +0.51%-3.07%+7.82%+17.11%

Financials

2026 *2027 *
Net sales 35.26B 3.64B 3.14B 2.97B 2.69B 5.05B 348B 5.07B 13.56B 177B 13.67B 13.37B 559B 37.24B 3.84B 3.31B 3.14B 2.84B 5.33B 367B 5.36B 14.32B 187B 14.43B 14.12B 590B
Net income 3.17B 327M 282M 267M 242M 453M 31.22B 456M 1.22B 15.88B 1.23B 1.2B 50.18B 3.53B 364M 314M 297M 269M 505M 34.77B 508M 1.36B 17.69B 1.37B 1.34B 55.9B
Net Debt 8.2B 846M 729M 691M 626M 1.17B 80.86B 1.18B 3.15B 41.14B 3.18B 3.11B 130B 5.96B 615M 530M 502M 455M 853M 58.74B 857M 2.29B 29.89B 2.31B 2.26B 94.43B
Logo Getinge AB
Getinge AB is a Sweden-based company operating within healthcare sector. The Company provides hospitals and Life Science institutions with products and solutions aimed at improving clinical outcomes and optimizing workflows. The Company’s reporting segments have the following activities: Acute Care Therapies develops solutions for life-sustaining care in acute health conditions. Life Science offers a comprehensive range of equipment, technical expertise and prevention consultation contamination in pharmaceutical production, biomedical research, production of medical equipment and in various laboratory applications. Surgical Workflows offers products and services for the effective disinfection and sterilization of instruments used in operations, operating tables and others hardware for operating rooms and advanced IT systems for efficient and secure workflows in hospitals.
Employees
11,758
Date Price Change Volume
11/09/26 US$24.09 -0.88% 556
10/09/26 US$24.31 -1.84% 542
09/09/26 US$24.76 -0.60% 605
08/09/26 US$24.91 -1.17% 1,440
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
234.40SEK
Average target price
247.60SEK
Spread / Average Target
+5.63%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!